Search

collaboration-LIBD

Boehringer Ingelheim and The Lieber Institute for Brain Development collaborate on centrally acting COMT inhibitors in neuropsychiatric disorders

FRONTLINE® becomes Brand of the Year 2021-22

FRONTLINE® becomes Brand of the Year 2021-2022 in World Branding Awards

SENVELGO Best New Product Companion Animals award

SENVELGO won the 2023 Animal Health Best New Product for Companion Animals award

China pioneers biosecurity report against ASF

Boehringer Ingelheim compiles data from 1,000 swine farms into the first market report on biosecurity. Document sheds light on livestock management and contributes to the fight against African swine fever.

Brazil boosts biosecurity in dairy farms

We partnered with Embrapa to help farmers and local authorities set best practices in biosecurity for dairy through a biosecurity certificate.

About cardio-renal-metabolic conditions

This page provides an overview of cardiovascular, renal, and metabolic conditions

inauguration_biopharmaceutical_production_facility_vienna

The state-of-the-art biopharmaceutical production facility in Vienna is the single largest investment in the company's history.

FreVAX smartphone application piglet vaccination

New FreVAX™ smartphone application brings piglet vaccination to another level

DiaTEC new purification technology Ingelvac CircoFLEX

Boehringer Ingelheim introduces DiaTEC, a new and proprietary purification technology for Ingelvac CircoFLEX®

Boehringer Ingelheim annouces 2020 BVDzero Case Awards

Boehringer Ingelheim is announcing the 2020 ‘BVDzero Case Awards’ are now open for applications. The bi-annual awards reflect the long-term commitment to promoting the health and well-being of farm animals.

Embracing diversity in clinical trials

At Boehringer Ingelheim, we understand the crucial need of embracing diversity in clinical trials as an opportunity to enable more equitable healthcare.

Reimagining digital healthcare worldwide

How does our digital lab BI X innovate in Ingelheim and Shanghai? Read about success stories based on different ideation processes

Listen to the sounds disrupting farms worldwide

A pioneer in Precision Livestock Farming, Prof. Daniel Berckmans reveals how online monitoring technology is bringing healthier pigs closer to farmers and consumers

Phase 1 start for novel triple agonist obesity treatment

Boehringer and Gubra announce Phase 1 study of BI 3034701, a long-acting, next generation, first-in-class triple agonist peptide for obesity treatment

Tips to help you start your patient advocacy journey

Advocating for yourself as a patient can be daunting. Jeff Dunn, President of Union for International Cancer Control (UICC), shares some tips

EMPRISE

Learn about the EMPRISE real-world evidence study and use of empagliflozin in routine clinical care

cat feline diabetes medication treatment fda approval

Boehringer Ingelheim receives FDA approval for SENVELGO®

Phase II results cognitive impairment schizophrenia

Presented at ECNP Congress, Phase II trial results demonstrated improvement in cognition with BI 425809 in schizophrenia patients

Aservo EquiHaler wins Pharmapack Award 2021

Boehringer Ingelheim’s Aservo® EquiHaler® is recognized in the 2021 Pharmapack Awards

Research ruminant animal health well-being

Boehringer Ingelheim supports young scientists and veterinarians dedicated to ruminant health research